Boiron SA (FRA:BON)

Market Cap	526.08M
Revenue (ttm)	504.86M
Net Income (ttm)	19.37M
Shares Out	n/a
EPS (ttm)	1.12
PE Ratio	27.16
Forward PE	19.27
Dividend	1.20 (3.91%)
Ex-Dividend Date	Jun 3, 2025

Volume	40
Average Volume	19
Open	29.90
Previous Close	29.60
Day's Range	29.90 - 30.70
52-Week Range	20.65 - 31.35
Beta	n/a
RSI	63.76
Earnings Date	Mar 20, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for ad...

• Industry: Pharmaceutical Preparations
• Founded: 1932
• Employees: 2,771
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BON

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.